|
Deepak Chadha, Vice President, Regulatory Affairs, is leading Kythera’s regulatory submissions and overseeing regulatory projects covering Kythera’s expansive product pipeline. Deepak brings to Kythera more than 13 years of experience in regulatory submissions and projects for drugs, biologics, medical devices and combination products. His most recent role was Vice President, Global Regulatory Affairs at Allergan Medical (formerly know as Inamed Corporation), where he helped build the Global Regulatory Affairs Department and was responsible for developing and implementing global regulatory strategies. Deepak led the group to successful submission and approval of aesthetic products in the U.S. and overseas. Prior to Allergan, Deepak held positions of increasing responsibility at Biomeasure Inc. (Ipsen) and Stryker Biotech in Massachusetts. At Biomeasure Inc., he oversaw the U.S. regulatory activities of Ipsen’s Botulinum Toxin Type-A development program for the aesthetic indication. His regulatory experience encompasses preparation and successful submission of clinical and marketing applications to the FDA, the EMEA, as well as the regulatory agencies of the United Kingdom, Canada, Australia, and Japan among others.
Deepak holds a BS in Pharmaceutical Sciences from Berhampur University in Orissa, India, an MS in Pharmaceutics from Hamdard University in New Delhi, India, and an MBA in International Business from California State University, Dominguez Hills | 